North-South Pharma

ProHub Comment

This is a well-structured case that combines market sizing with profitability analysis and strategic brainstorming. The case tests quantitative skills (market sizing and contribution margin analysis), analytical thinking (comparing facility economics), and creative problem-solving (brainstorming alternatives for the idle facility). The key insight is recognizing that high transportation costs make the SA facility unprofitable for serving US customers, but it could potentially be viable for local South American markets.

Estimated Time 15 minutes
Difficulty Medium
Source Darden
50 / 100

North-South Pharma Co is a US-based pharmaceutical manufacturer. The company owns a plant in the United States that is active in serving US customers through pharmacies, and also owns an idle plant in South America.

  1. Market Size: Forecast Revenue for North-South Pharma Co
  2. What should North-South Pharma Co do with its idle South American facility

Clarifying Information

  1. Revenue per prescription: $0.50
  2. US plant - Labor: $0.10, Raw Materials: $0.10, Transportation: $0.05, Fixed Cost: $5,000,000, Capacity: 50,000,000
  3. South America plant - Labor: $0.05, Raw Materials: $0.05, Transportation: $0.20, Fixed Cost: $4,000,000, Capacity: 20,000,000
  4. Max necessary production (based on market sizing): 30,000,000 prescriptions
  5. US facility profit: $2,500,000
  6. SA facility profit: $0 (breaking even)